Acromegaly

Acromegaly is a rare but serious endocrine disorder that results from prolonged overproduction of growth hormone (GH), usually due to a benign pituitary adenoma. Excess GH stimulates the liver to produce insulin-like growth factor 1 (IGF-1), which drives abnormal tissue growth and metabolic changes.

The condition develops gradually, often going unnoticed for years. Common physical changes include enlarged hands and feet, thickened facial features, jaw protrusion, and skin changes. Patients may also experience joint pain, fatigue, headaches, and vision problems due to tumor pressure on surrounding structures. Beyond physical appearance, acromegaly can lead to significant health complications such as hypertension, diabetes mellitus, sleep apnea, and cardiovascular disease.

Diagnosis involves measuring GH and IGF-1 levels, along with imaging studies like MRI to detect pituitary tumors. Treatment options include surgical removal of the adenoma, medical therapy to suppress GH secretion, and radiation therapy for residual tumor tissue. Early intervention is crucial to prevent irreversible changes and reduce long-term risks.

Although acromegaly is chronic, effective management can control hormone levels, alleviate symptoms, and improve quality of life. Regular monitoring and multidisciplinary care are essential to ensure patients live healthier, longer lives despite the challenges of this condition.